Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia.

about

Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia.

Item

http://www.wikidata.org/entity/Q37443163

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@en

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@nl

type

Item

label

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@en

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@nl

prefLabel

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@en

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@nl

P1476

Total Body Irradiation without ...... Adult Acute Myeloid Leukemia.

@en

P2093

Christopher Bredeson

http://www.w3.org/2001/XMLSchema#string

Dawn Maze

http://www.w3.org/2001/XMLSchema#string

Harry Atkins

http://www.w3.org/2001/XMLSchema#string

Lothar Huebsch

http://www.w3.org/2001/XMLSchema#string

Rajiv Samant

http://www.w3.org/2001/XMLSchema#string

Sultan Altouri

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

Primary refractory acute myeloid leukaemia - in search of better definitions and therapies.

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation

Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

P304

1257679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/1257679

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

David S. Allan

Mitchell Sabloff

P577

2016-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27957357

http://www.w3.org/2001/XMLSchema#string

P932

5124456

http://www.w3.org/2001/XMLSchema#string